Summit Therapeutics (SMMT) shares fell 37%, or $13.49, to $23.21 before halting for news. BioNTech (BNTX) dropped in sympathy, down 15% to $102.85.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMMT: